SCHEMBL18258290

SCHEMBL18258290

NC1=CCC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28125978 0.85
SCHEMBL6724092 0.79
SCHEMBL23430392 0.75
SCHEMBL1654819 0.74
SCHEMBL25119294 0.72
SCHEMBL13750289 0.69
SCHEMBL18627189 0.67
SCHEMBL19594957 0.67
SCHEMBL21637658 0.67
SCHEMBL18726539 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817359-B1 CUCURBITURIL-BASED HYDROGELS CAMBRIDGE ENTPR LTD (GB) 2019-09-11 EP disclosed
EP-3083630-B1 PROCESS METHODS FOR PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD CALISTOGA LLC (US) 2019-08-21 EP disclosed
EP-2276346-B1 FUSED BICYCLIC PYRIMIDINE COMPOUNDS AS AURORA KINASE INHIBITORS NAT HEALTH RESEARCH INSTITUTES (TW) 2016-11-23 EP disclosed